BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29039324)

  • 1. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides.
    Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H
    Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, enzyme inhibition and molecular docking studies of 1-Arylsulfonyl-4-phenylpiperazine derivatives.
    Abbasi MA; Anwar A; Rehman A; Siddiqui SZ; Rubab K; Shah SAA; Lodhi MA; Khan FA; Ashraf M; Alam U
    Pak J Pharm Sci; 2017 Sep; 30(5):1715-1724. PubMed ID: 29084694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological screening and molecular docking studies of some ethylated sulfonamides having 1,4-Benzodioxane moiety.
    Irshad M; Abbasi MA; Rehman AR; Siddiqui SZ; Ali MS; Ashraf M; Ismail T; Ahmad I; Hassan S; Lodhi MA; Jamal SB
    Pak J Pharm Sci; 2016 Nov; 29(6):1913-1925. PubMed ID: 28375106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Molecular Docking Studies of Novel Biheterocyclic Propanamides as Antidiabetic Agents Having Mild Cytotoxicity.
    Abbasi MA; Rubab K; Aziz-Ur-Rehman ; Siddiqui SZ; Hassan M; Raza H; Shah SAA; Shahid M; Kloczkowski A
    ACS Omega; 2023 Jun; 8(25):22899-22911. PubMed ID: 37396264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents.
    Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH
    Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 2-amino-4-(5'-substituted 2'-phenyl-1H-indol-3'-yl)-6-aryl-4H-pyran-3-carbonitrile derivatives as antimicrobial and antioxidant agents.
    Saundane AR; Vijaykumar K; Vaijinath AV
    Bioorg Med Chem Lett; 2013 Apr; 23(7):1978-84. PubMed ID: 23454016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamides as possible therapeutic agents for Alzheimer's disease and Type-2 Diabetes.
    Abbasi MA; Rehman A; Siddiqui SZ; Hadi N; Mumtaz A; Shah SAA; Ashraf M; Abbasi GH
    Pak J Pharm Sci; 2019 Jan; 32(1):61-68. PubMed ID: 30772791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-{[5-(Substituted-phenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamides: New bi-heterocycles as possible therapeutic agents.
    Ramzan MS; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Mirza B; Ismail H
    Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1051-1059. PubMed ID: 29731443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, spectral analysis and antibacterial evaluation of N'-substituted-2-(5-(3-chlorophenyl)-1,3,4-Oxadiazol-2-ylthio)acetohydrazide derivatives.
    Rehman AU; Rasool S; Abbasi MA; Siddiqui SZ
    Pak J Pharm Sci; 2016 Jul; 29(4):1307-15. PubMed ID: 27393454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of some new biologically active N-substituted-2''- [(phenylsulfonyl)(piperidin-1-yl)amino]acetamide derivatives.
    Khalid H; Rehman AU; Abbasi MA; Siddiqui SZ; Malik A; Ashraf M; Ahmad I; Ejaz SA
    Pak J Pharm Sci; 2014 May; 27(3):517-24. PubMed ID: 24811811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives.
    Siddiqui N; Alam MS; Ahsan W
    Acta Pharm; 2008 Dec; 58(4):445-54. PubMed ID: 19103578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimicrobial activity of N-[(alpha-methyl)benzylidene]-(3-substituted-1,2,4-triazol-5-yl-thio) acetohydrazides.
    Ersan S; Nacak S; Berkem R
    Farmaco; 1998 Dec; 53(12):773-6. PubMed ID: 10230058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-[(5-benzyl-1,3,4-oxadiazole-2yl)sulfanyl]-N-(arylated/arenylated) acetamides as antibacterial and acetyl cholinesterase inhibitors.
    Siddiqui SZ; Abbasi MA; Rehman A; Ashraf M; Mirza B; Ismail H
    Pak J Pharm Sci; 2017 Sep; 30(5):1743-1751. PubMed ID: 29084697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
    Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
    Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of New 3-Heteroarylindoles as Potential Anticancer Agents.
    Abdelhamid AO; Gomha SM; Abdelriheem NA; Kandeel SM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
    Huan LC; Tran PT; Phuong CV; Duc PH; Anh DT; Hai PT; Huong LTT; Thuan NT; Lee HJ; Park EJ; Kang JS; Linh NP; Hieu TT; Oanh DTK; Han SB; Nam NH
    Bioorg Chem; 2019 Nov; 92():103202. PubMed ID: 31479984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bi-heterocyclic benzamides as alkaline phosphatase inhibitors: Mechanistic comprehensions through kinetics and computational approaches.
    Abbasi MA; Nazir M; Ur-Rehman A; Siddiqui SZ; Hassan M; Raza H; Shah SAA; Shahid M; Seo SY
    Arch Pharm (Weinheim); 2019 Mar; 352(3):e1800278. PubMed ID: 30624805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of synthetic multifunctional amides as new therapeutic agents for Alzheimer's disease through enzyme inhibition, chemoinformatic properties, molecular docking and dynamic simulation insights.
    Hassan M; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Hussain G; Shah SAA; Shahid M; Seo SY
    J Theor Biol; 2018 Dec; 458():169-183. PubMed ID: 30243565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of novel
    Huan LC; Anh DT; Hai PT; Anh LD; Park EJ; Ji AY; Kang JS; Dung DTM; Oanh DTK; Tung TT; Hai DTT; Han SB; Nam NH
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1854-1865. PubMed ID: 32981382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of
    Bashir B; Riaz N; Ejaz SA; Saleem M; Iqbal A; Ashraf M; Ejaz S; -Rehman AU; Aziz M; Bhattarai K
    J Biomol Struct Dyn; 2023; 41(24):15549-15568. PubMed ID: 36946200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.